학술논문

PKC agonism restricts innate immune suppression, promotes antigen cross-presentation and synergizes with agonistic CD40 antibody therapy to activate CD8+ T cells in breast cancer
Document Type
Article
Source
In: Cancer Letters. (Cancer Letters, 10 April 2022, 531:98-108)
Subject
Language
English
ISSN
18727980
03043835